Yesterday the Access to Breast Cancer Diagnosis Act was introduced in the House of Representatives and Senate – ACS CAN
American Cancer Society Cancer Action Network (ACS CAN) shared on LinkedIn:
“Yesterday the Access to Breast Cancer Diagnosis Act was introduced in the House of Representatives and Senate. The ACBD Act helps remove financial barriers to imaging and screening tests used to diagnose Breast Cancer, including MRIs, ultrasound, and mammograms.
‘Out-of-pocket cost sharing is a significant barrier for those individuals who need access to multiple early detection services in order to find cancer at an earlier stage when treatment is more effective,’ said Lisa A. Lacasse, president of ACS CAN. ‘These additional expenses can lead to delayed or even skipped medically necessary procedures resulting in potentially life-threatening consequences. Removing cost sharing for each intervention in the screening process is a critical step toward ending cancer as we know it, for everyone.’
ACS CAN urges Congress to swiftly pass this important legislation to help make breast cancer diagnostic tests more accessible, which can help reduce the cancer burden and save more lives.”
Read this insightful article about Breast Cancer on OncoDaily: “Triple-Negative Breast Cancer: Symptoms ,Causes, Types, Diagnosis and Treatment”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023